Ueda, S.; Miura, K.; Kawasaki, H.; Ogata, S.; Yamasaki, N.; Miura, S.; Mori, A.; Kaminuma, O.
Th17-Dependent Nasal Hyperresponsiveness Is Mitigated by Steroid Treatment. Biomolecules 2022, 12, 674.
https://doi.org/10.3390/biom12050674
AMA Style
Ueda S, Miura K, Kawasaki H, Ogata S, Yamasaki N, Miura S, Mori A, Kaminuma O.
Th17-Dependent Nasal Hyperresponsiveness Is Mitigated by Steroid Treatment. Biomolecules. 2022; 12(5):674.
https://doi.org/10.3390/biom12050674
Chicago/Turabian Style
Ueda, Shusaku, Kento Miura, Hideki Kawasaki, Sawako Ogata, Norimasa Yamasaki, Shuka Miura, Akio Mori, and Osamu Kaminuma.
2022. "Th17-Dependent Nasal Hyperresponsiveness Is Mitigated by Steroid Treatment" Biomolecules 12, no. 5: 674.
https://doi.org/10.3390/biom12050674
APA Style
Ueda, S., Miura, K., Kawasaki, H., Ogata, S., Yamasaki, N., Miura, S., Mori, A., & Kaminuma, O.
(2022). Th17-Dependent Nasal Hyperresponsiveness Is Mitigated by Steroid Treatment. Biomolecules, 12(5), 674.
https://doi.org/10.3390/biom12050674